Welcure Drugs & Pharmaceuticals Ltd Financial Ratios
WELCURE · Healthcare · Current price ₹0.2
P/E ratio
-5.5x
P/B ratio
0.3x
ROE
-5.7%
ROCE
-5.7%
Debt / Equity
0.00
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -5.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -5.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -5.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Welcure Drugs & Pharmaceuticals Ltd's latest numbers.
Welcure Drugs & Pharmaceuticals Ltd profitability
Welcure Drugs & Pharmaceuticals Ltd generates a return on equity of -5.7% and a return on capital employed of -5.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of -5.5x, Welcure Drugs & Pharmaceuticals Ltd is conservatively financed. Our overall business-quality score for the company is 3.2 / 10.
Understand the ratios
More on Welcure Drugs & Pharmaceuticals Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.